CAMKK2 and early-onset autosomal dominant Alzheimer disease: An emerging body of data suggest that aberrant activation of the CaMKK2-AMPK pathway may be involved in the pathogenesis of neurodegenerative diseases such as Alzheimer’s disease, the most common form of dementia [52].